Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
(NASDAQ: DNLI) Delayed: 20.13 +0.07 (0.35%)
Previous Close $20.06    52 Week High $ 
Open $20.57    52 Week Low $ 
Day High $20.65    P/E N/A 
Day Low $19.90    EPS $ 
Volume 1,421,384